Cargando…
Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study
Psychoneurological symptom clusters are co-occurring and interrelated physiological symptoms that may include cancer-related fatigue, pain, depressive symptoms, cognitive disturbances, and sleep disturbances. These symptoms are hypothesized to share a common systemic proinflammatory etiology. Thus,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385103/ https://www.ncbi.nlm.nih.gov/pubmed/34429399 http://dx.doi.org/10.1038/s41398-021-01554-w |
_version_ | 1783742023735443456 |
---|---|
author | Sass, Dilorom Saligan, Leorey Fitzgerald, Wendy Berger, Ann M. Torres, Isaias Barb, Jennifer J. Kupzyk, Kevin Margolis, Leonid |
author_facet | Sass, Dilorom Saligan, Leorey Fitzgerald, Wendy Berger, Ann M. Torres, Isaias Barb, Jennifer J. Kupzyk, Kevin Margolis, Leonid |
author_sort | Sass, Dilorom |
collection | PubMed |
description | Psychoneurological symptom clusters are co-occurring and interrelated physiological symptoms that may include cancer-related fatigue, pain, depressive symptoms, cognitive disturbances, and sleep disturbances. These symptoms are hypothesized to share a common systemic proinflammatory etiology. Thus, an investigation of systemic immune biomarkers is an important approach to test this hypothesis. Here, we investigated the associations between extracellular vesicle (EV)-associated and soluble cytokines with immune markers and symptom clusters in men with non-metastatic prostate cancer. This observational study included 40 men with non-metastatic prostate cancer at the start (T1) of external beam radiation therapy (EBRT) and 3 months post treatment (T2), as well as 20 men with non-metastatic prostate cancer on active surveillance (AS) seen at one time point. Collected questionnaires assessed patient-reported fatigue, sleep disturbances, depressive symptoms, and cognitive fatigue. In total, 45 soluble and EV-associated biomarkers in plasma were determined by multiplex assays. Principal component analysis (PCA) was used to identify psychoneurological symptom clusters for each study group and their time points. Bivariate correlation analysis was run for each identified PCA cluster with the concentrations of EV-associated and soluble cytokines and immune markers. Both EV-associated and soluble forms of RANTES significantly correlated with the symptom cluster for EBRT at T1, whereas, at T2, soluble IFNα2, IL-9, and IL-17 correlated with the corresponding symptom cluster. For the AS group, soluble survivin correlated with psychoneurological symptoms. Linking specific inflammatory cytokines with psychoneurological symptom clusters in men receiving prostate cancer treatment can enhance understanding of the underlying mechanisms of this phenomenon and aid in developing targeted interventions. |
format | Online Article Text |
id | pubmed-8385103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-83851032021-09-14 Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study Sass, Dilorom Saligan, Leorey Fitzgerald, Wendy Berger, Ann M. Torres, Isaias Barb, Jennifer J. Kupzyk, Kevin Margolis, Leonid Transl Psychiatry Article Psychoneurological symptom clusters are co-occurring and interrelated physiological symptoms that may include cancer-related fatigue, pain, depressive symptoms, cognitive disturbances, and sleep disturbances. These symptoms are hypothesized to share a common systemic proinflammatory etiology. Thus, an investigation of systemic immune biomarkers is an important approach to test this hypothesis. Here, we investigated the associations between extracellular vesicle (EV)-associated and soluble cytokines with immune markers and symptom clusters in men with non-metastatic prostate cancer. This observational study included 40 men with non-metastatic prostate cancer at the start (T1) of external beam radiation therapy (EBRT) and 3 months post treatment (T2), as well as 20 men with non-metastatic prostate cancer on active surveillance (AS) seen at one time point. Collected questionnaires assessed patient-reported fatigue, sleep disturbances, depressive symptoms, and cognitive fatigue. In total, 45 soluble and EV-associated biomarkers in plasma were determined by multiplex assays. Principal component analysis (PCA) was used to identify psychoneurological symptom clusters for each study group and their time points. Bivariate correlation analysis was run for each identified PCA cluster with the concentrations of EV-associated and soluble cytokines and immune markers. Both EV-associated and soluble forms of RANTES significantly correlated with the symptom cluster for EBRT at T1, whereas, at T2, soluble IFNα2, IL-9, and IL-17 correlated with the corresponding symptom cluster. For the AS group, soluble survivin correlated with psychoneurological symptoms. Linking specific inflammatory cytokines with psychoneurological symptom clusters in men receiving prostate cancer treatment can enhance understanding of the underlying mechanisms of this phenomenon and aid in developing targeted interventions. Nature Publishing Group UK 2021-08-24 /pmc/articles/PMC8385103/ /pubmed/34429399 http://dx.doi.org/10.1038/s41398-021-01554-w Text en © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Sass, Dilorom Saligan, Leorey Fitzgerald, Wendy Berger, Ann M. Torres, Isaias Barb, Jennifer J. Kupzyk, Kevin Margolis, Leonid Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study |
title | Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study |
title_full | Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study |
title_fullStr | Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study |
title_full_unstemmed | Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study |
title_short | Extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study |
title_sort | extracellular vesicle associated and soluble immune marker profiles of psychoneurological symptom clusters in men with prostate cancer: an exploratory study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385103/ https://www.ncbi.nlm.nih.gov/pubmed/34429399 http://dx.doi.org/10.1038/s41398-021-01554-w |
work_keys_str_mv | AT sassdilorom extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy AT saliganleorey extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy AT fitzgeraldwendy extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy AT bergerannm extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy AT torresisaias extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy AT barbjenniferj extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy AT kupzykkevin extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy AT margolisleonid extracellularvesicleassociatedandsolubleimmunemarkerprofilesofpsychoneurologicalsymptomclustersinmenwithprostatecanceranexploratorystudy |